Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$37,744,792
+$15,651,233 QoQ
Shares Held
443,066
+32.2% QoQ
Ownership
0.319%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#67
of 477 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. CYTK ranks #18 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in CYTK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,744,792 | 443,066 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $22,093,559 | 335,208 | Shares | Sole | 2026-04-30 | |
| 2025-03-31 | $5,835,226 | 145,191 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,023,142 | 170,560 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $9,461,760 | 179,200 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,709,056 | 179,200 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $34,566,263 | 493,029 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $22,311,867 | 267,240 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,825,450 | 503,240 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,557,388 | 538,240 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $18,940,665 | 538,240 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,058,456 | 503,240 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $24,381,978 | 503,240 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $20,449,502 | 520,476 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $23,566,792 | 640,228 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $23,398,219 | 513,344 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $18,346,914 | 513,344 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $10,159,077 | 513,344 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $8,742,340 | 375,853 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $7,810,225 | 375,853 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $3,035,871 | 140,225 | Shares | Sole | 2020-10-19 | |
| No filing history on record for this holder in this stock. | ||||||